cb 3703 has been researched along with folic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grzelakowska-Sztabert, B; Sikora, F | 1 |
| Grzelakowska-Sztabert, B; Sikora, E | 1 |
| Calvert, AH; Dady, PJ; Grzelakowska-Sztabert, B; Harrap, KR; Jones, TR; Paine, RM; Taylor, GA | 1 |
3 other study(ies) available for cb 3703 and folic acid
| Article | Year |
|---|---|
Quinazoline CB 3717 and CB 3703 inhibition of folate retention and metabolism in Ehrlich ascites carcinoma cells and some organs of the host-mouse.
Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Folic Acid; Folic Acid Antagonists; Kidney; Liver; Mice; Quinazolines | 1984 |
A quinazoline antifolate as inhibitor of folate metabolism in mouse L-cells.
Topics: Animals; Folic Acid; Folic Acid Antagonists; Glutamates; L Cells; Lethal Dose 50; Mice; Quinazolines | 1983 |
Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance.
Topics: Animals; Cell Survival; Female; Folic Acid; Folic Acid Antagonists; Leukemia L1210; Methotrexate; Mice; Quinazolines; Thymidylate Synthase | 1980 |